Cargando...
Mechanisms and Management of Immune Checkpoint Inhibitor-Related Cardiac Adverse Events
Onco-cardiology recently emerged as a novel discipline to provide effective cardioprotective care against cancer therapeutics-related cardiac adverse events (CAEs) and support the continuity of optimal cancer treatment. Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy and drama...
Gardado en:
| Publicado en: | JMA J |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Japan Medical Association
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8118963/ https://ncbi.nlm.nih.gov/pubmed/33997442 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31662/jmaj.2021-0001 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|